123 related articles for article (PubMed ID: 15586228)
41. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
42. Induction of RANTES by TWEAK/Fn14 interaction in human keratinocytes.
Jin L; Nakao A; Nakayama M; Yamaguchi N; Kojima Y; Nakano N; Tsuboi R; Okumura K; Yagita H; Ogawa H
J Invest Dermatol; 2004 May; 122(5):1175-9. PubMed ID: 15140220
[TBL] [Abstract][Full Text] [Related]
43. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
Shui Y; Guan ZB; Zhang SQ
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
[TBL] [Abstract][Full Text] [Related]
44. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
[TBL] [Abstract][Full Text] [Related]
45. TWEAK stimulation of astrocytes and the proinflammatory consequences.
Saas P; Boucraut J; Walker PR; Quiquerez AL; Billot M; Desplat-Jego S; Chicheportiche Y; Dietrich PY
Glia; 2000 Oct; 32(1):102-7. PubMed ID: 10975915
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
Yepes M; Winkles JA
Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
[TBL] [Abstract][Full Text] [Related]
48. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma.
Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N
Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273
[TBL] [Abstract][Full Text] [Related]
49. Sustained activation of protein kinase C downregulates nuclear factor-kappaB signaling by dissociation of IKK-gamma and Hsp90 complex in human colonic epithelial cells.
Park KA; Byun HS; Won M; Yang KJ; Shin S; Piao L; Kim JM; Yoon WH; Junn E; Park J; Seok JH; Hur GM
Carcinogenesis; 2007 Jan; 28(1):71-80. PubMed ID: 16774932
[TBL] [Abstract][Full Text] [Related]
50. IFN-alpha competes with TNF-alpha for STAT-1alpha; molecular basis for immune escape of human colon adenocarcinoma COLO 205 cells.
Pajak B; Orzechowski A
Oncol Rep; 2007 Oct; 18(4):1039-45. PubMed ID: 17786371
[TBL] [Abstract][Full Text] [Related]
51. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis.
Jenkins PJ; Khalaf S; Ogunkolade W; McCarthy K; David T; Hands RE; Davies D; Bustin SA
Endocr Relat Cancer; 2005 Dec; 12(4):891-901. PubMed ID: 16322329
[TBL] [Abstract][Full Text] [Related]
52. 4-O-methylgallic acid down-regulates endothelial adhesion molecule expression by inhibiting NF-kappaB-DNA-binding activity.
Lee G; Na HJ; Namkoong S; Jeong Kwon H; Han S; Ha KS; Kwon YG; Lee H; Kim YM
Eur J Pharmacol; 2006 Dec; 551(1-3):143-51. PubMed ID: 17027748
[TBL] [Abstract][Full Text] [Related]
53. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
54. [Effects of nuclear factor-kappaB decoy oligodeoxynucleotide on the function of human umbilical artery smooth muscle cells induced by umbilical sera in preeclampsia].
Jiang RZ; Huang YJ; Gu JH; Mu WH; Chen HP
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):87-91. PubMed ID: 17442180
[TBL] [Abstract][Full Text] [Related]
55. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
56. Considering TWEAK as a target for therapy in renal and vascular injury.
Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM
Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
Potrovita I; Zhang W; Burkly L; Hahm K; Lincecum J; Wang MZ; Maurer MH; Rossner M; Schneider A; Schwaninger M
J Neurosci; 2004 Sep; 24(38):8237-44. PubMed ID: 15385607
[TBL] [Abstract][Full Text] [Related]
58. Down-regulated expression of TWEAK mRNA in acute and chronic inflammatory pathologies.
Chicheportiche Y; Fossati-Jimack L; Moll S; Ibnou-Zekri N; Izui S
Biochem Biophys Res Commun; 2000 Dec; 279(1):162-5. PubMed ID: 11112433
[TBL] [Abstract][Full Text] [Related]
59. Analyzing the signaling capabilities of soluble and membrane TWEAK.
Trebing J; Arana JA; Salzmann S; Wajant H
Methods Mol Biol; 2014; 1155():31-45. PubMed ID: 24788171
[TBL] [Abstract][Full Text] [Related]
60. Evidence for tumor necrosis factor receptors (TNFRs) in human MRC5 fibroblast cells.
Derouich-Guergour D; Pelloux H; Aldebert D; Demenge P; Ambroise-Thomas P
Eur Cytokine Netw; 2001 Mar; 12(1):147-53. PubMed ID: 11282559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
